A Study to Evaluate the Effectiveness and Safety of Polatuzumab in Real World Clinical Practice Among Adult Chinese Participants With Diffuse Large B-Cell Lymphoma

Peking Union Medical College Hospital, Beijing

Peking University Third Hospital, Beijing

Beijing Hospital of Ministry of Health, Beijing

Beijing Tongren Hospital, Capital Medical University, Beijing

China Medical University (CMU) First Affiliated Hospital, Shenyang

Ruijin Hospital Shanghai Jiaotong University School of Medicine, Shanghai

Tongji Hospital of Tongji University, Shanghai

Jiangsu Province Hospital (the First Affiliated Hospital With Nanjing Medical University), Nanjing

Jiangsu Cancer Hospital, Nanjing

Wuxi People's Hospital, Wuxi

Tianjin Medical University General Hospital, Tianjin

Tianjin Cancer Hospital, Tianjin

Jiangxi Cancer Hospital, Nanchang

Xiangya Hospital of Centre-South University, Changsha

Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan

Zhujiang Hospital, Southern Medical University, Guangzhou

Guizhou Cancer Hospital, Guiyang

Sichuan Academy of Medical Sciences and Sichuan Provincial Peoples Hospital, Chengdu

First Affiliated Hospital of Medical College of Xi'an Jiaotong University, Xi'an

Xinjiang Medical University Cancer Hospital, Ürümqi

The First Bethune Hospital of Jilin University, Changchun

Third Xiangya Hospital of Central South University, Changsha

Hainan Cancer Hospital, Haikou

The Fourth Hospital of Hebei Medical University, Shijiazhuang

The Affiliated Hospital of Xuzhou Medical University, Xuzhou

Henan Cancer Hospital, Zhengzhou

Affiliated Hospital of Inner Mongolia Medical University, Hohhot

The Affiliated Hospital Of Qingdao University, Qingdao

Shanxi Province Cancer Hospital, Taiyuan